|
|
Volumn , Issue 37, 2010, Pages 28-30
|
|
Changes to the art guidelines - An overview
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABACAVIR;
ANTIRETROVIRUS AGENT;
DIDANOSINE;
EFAVIRENZ;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
LAMIVUDINE;
LOPINAVIR PLUS RITONAVIR;
NEVIRAPINE;
STAVUDINE;
VIRUS DNA;
ZIDOVUDINE;
ABSENCE OF SIDE EFFECTS;
DNA VIRUS;
DRUG DOSE REGIMEN;
DRUG TREATMENT FAILURE;
HEALTH PROGRAM;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MOTHER CHILD RELATION;
PRACTICE GUIDELINE;
PREGNANT WOMAN;
SALVAGE THERAPY;
SHORT SURVEY;
SINGLE DRUG DOSE;
SOUTH AFRICA;
TREATMENT DURATION;
VIRUS LOAD;
VIRUS TRANSMISSION;
WORLD HEALTH ORGANIZATION;
|
|
EID: 77953418007
PISSN: 16089693
EISSN: None
Source Type: Journal
DOI: 10.4102/sajhivmed.v11i1.242 Document Type: Short Survey |
|
Times cited : (4)
|
|
References (0)
|
